Chenxi Wu
Impact in
- Drug Discovery top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Wnt/β-catenin signaling in development and cancer 5
- Ubiquitin and proteasome pathways 4
- FOXO transcription factor regulation 4
- RNA Interference and Gene Delivery 3
- Immunology 13
- Invertebrate Immune Response Mechanisms 4
- Immunotherapy and Immune Responses 4
- Co-authors
- Tianmeng Sun (10 shared papers)Jialiang Wang (7 shared papers)Hongmei Chen (7 shared papers)Yong‐Guang Yang (7 shared papers)Kuirong Mao (7 shared papers)Xiuxiu Cong (7 shared papers)Gang Niu (1 shared paper)Lei Zhu (1 shared paper)
- Journals
- Biomaterials Science (4 papers)Frontiers in Pharmacology (3 papers)Biomaterials (3 papers)Journal of Ethnopharmacology (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- ChinaUnited StatesCroatia
In The Last Decade
Chenxi Wu
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 108
- Drug Discovery 2
- Immunology 226
- Cancer Research 154
- Biomaterials 137
- Aging 17
Countries citing papers authored by Chenxi Wu
This map shows the geographic impact of Chenxi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Wu more than expected).
Fields of papers citing papers by Chenxi Wu
This network shows the impact of papers produced by Chenxi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Wu. The network helps show where Chenxi Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenxi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 138 | |
| 2 | 2022 | 102 | |
| 3 | 2011 | 91 | |
| 4 | 2013 | 76 | |
| 5 | 2020 | 74 | |
| 6 | 2020 | 73 | |
| 7 | 2023 | 64 | |
| 8 | 2014 | 57 | |
| 9 | 2017 | 50 | |
| 10 | 2023 | 48 | |
| 11 | 2015 | 48 | |
| 12 | 2017 | 41 | |
| 13 | 2012 | 37 | |
| 14 | 2019 | 32 | |
| 15 | 2018 | 30 | |
| 16 | 2020 | 27 | |
| 17 | 2021 | 26 | |
| 18 | 2019 | 22 | |
| 19 | 2013 | 21 | |
| 20 | 2023 | 21 |
About Chenxi Wu
Chenxi Wu is a scholar working on Molecular Biology, Immunology, Cell Biology, Biomedical Engineering and Oncology, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (8 papers), Nanoplatforms for cancer theranostics (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers), Invertebrate Immune Response Mechanisms (4 papers), Immunotherapy and Immune Responses (4 papers), FOXO transcription factor regulation (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Drug Discovery (2 citations), Immunology (226 citations), Cancer Research (154 citations), Biomaterials (137 citations) and Aging (17 citations). Chenxi Wu has collaborated with scholars based in China, United States and Croatia. Frequent co-authors include Tianmeng Sun, Jialiang Wang, Hongmei Chen, Yong‐Guang Yang, Kuirong Mao, Xiuxiu Cong, Gang Niu, Lei Zhu, Zhuang Liu and Xiaolian Sun. Their work appears in journals such as Biomaterials Science, Frontiers in Pharmacology, Biomaterials, Journal of Ethnopharmacology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.